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Abstract
Background: Five to 10 % of children with neuroblastoma present with symptoms of epidural compression (EC).
More than half these patients are diagnosed in the first year of life. The case of a neuroblastoma presenting
symptoms of EC at birth is exceptional and deserves to be reported.
Case presentation: We describe a case of female born at the 36th week of pregnancy by caesarian section decided
following ultrasonographic discovery of oligohydramnios. At birth, she was noted to have motor deficit involving
both legs and continuous urinary dripping. These symptoms were found to be secondary to a paraspinal
neuroblastoma infiltrating the spinal canal. Tumor responded well to chemotherapy, but neurologic deficit only
slightly improved and bladder dysfunction remained unchanged. At 2 years of age, patient is able to walk with help
of leg orthoses, suffers chronic constipation requiring daily medications, and has neurologic bladder necessitating
multiple daily catheterizations.
Conclusions: The finding of a newborn presenting with symptoms of EC secondary to a neuroblastoma invading
the spinal canal is quite uncommon. The case described herewith confirms that these rare patients have an
excellent survival probability, but almost always develop severe functional sequelae.
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Background
Neuroblastoma accounts for 8–10 % of pediatric cancers
[1]. Five to 10 % of children with neuroblastoma present
with symptoms of epidural compression (EC) [2, 3].
More than half these patients are diagnosed in the first
year of life [4]. These young patients have a high survival
probability, but almost all develop severe sequelae [4, 5].
The discovery of a neuroblastoma associated with EC at
birth is a rare event [6], as witnessed by the fact that
only 0.2 % of all diagnoses of this tumour were regis-
tered by the Italian Association of Hematology and
Oncology (AIEOP) Neuroblastoma Registry over a
period of 10 years [7]. The literature concerning these
patients is limited to a small number of mostly single-
case reports [6, 8–16]. We describe herewith a newborn
whose delivery was anticipated to the 36th week of preg-
nancy for olygohydramnios and was found to have
motor deficit and bladder dysfunction at birth secondary
to an abdominal neuroblastoma.
Case presentation
A female was delivered on February 28, 2014, by caesarian
section performed on the 36thweek of pregnancy following
the ultrasonographic discovery of severe oligohydramnios.
The examination was read negative for the presence of ab-
dominal masses and did not document reduced foetal
movements. Birth weight was 2300 grams. Apgar score
was within normal limits. Physical examination in the first
day of life showed hypotonia and no motility of legs, and
distended bladder with continuous urinary dripping
requiring catheterization. Spinal Magnetic resonance im-
aging (MRI) was performed on the 2nd day of life and
showed a solid retroperitoneal mass, 4×1.5 cm in diameter,
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entering the spinal canal through the foramina from D11-
12 until L2-L3 (Fig. 1). This finding, together with the ele-
vated excretion of urinary vanillylmandelic acid, was sug-
gestive of a peripheral neuroblastic tumor (PNT).
Following multidisciplinary discussion and achievement of
family consent, decision was taken to avoid the neurosurgi-
cal approach in favor of chemotherapy. Based on the guide-
lines of the International Society of Pediatric Oncology
Europe Neuroblastoma (SIOPEN) for symptomatic PNTs
presenting with EC [17], an association of carboplatin and
etoposide was initiated on day 6 from birth (Table 1). Tru-
cut biopsy of the extraspinal tumor was performed on day
21 of life. The histopathologic examination revealed a
Schwannian stroma-poor, poorly differentiated neuroblast-
oma composed of undifferentiated, primitive-appearing,
round blue cells in a nesting pattern (Fig. 2). Focally, these
cells were embedded in a clearly recognizable neuropil [18].
Immunoreactivity for thyrosinase, CD56, synaptophysin,
chromogranin, neuron-specific enolase and negativity for
CD99, actin, CD45, WT1, CK, and CD34 were read nega-
tive. Due to the scarcity of the available tissue no biologic
studies could be performed. Two bone marrow aspirates
were found free of tumor cells. On day 33, meta-
iodobenzylguanidine (MIBG) scintigraphy showed intense
positivity at site of the tumor and no metastatic lesions.
Tumor extension was thus defined as International Neuro-
blastoma Staging System (INSS) stage 3 [19]. At the MRI
performed after 4 chemotherapy courses (on day 103), the
intraspinal tumor appeared markedly decreased. At this
time, the MIBG-positive lesion had disappeared. Neuro-
logically, the motor deficit had progressively decreased,
Fig. 1 MRI at diagnosis. Three planar T2WI (a, b, c). Retroperitoneal neuroblastoma with intraspinal invasion. Left-sided large mass with dumbbell
extension through widened neural foramina (a and b, white arrows) and marked compression and dislocation of the cauda (a, black arrow)
Table 1 Drug dosages and schedules
Drug Associations Drugs Days
Carbo/VP • Carboplatin 4 mg/kg 1–3




• Doxorubicin 1 mg/kg 4–5
• Vincristine 0.05 mg/kg 1 and 5, repeated after
4 weeks
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more for the left leg, while bladder dysfunction was un-
changed. Based on clinical and imaging responses, antitu-
mor therapy was stopped. Patient was included in an
intensive physiotherapy program aiming to further improve
motor deficit and flexibility of lower limbs.
At the follow-up evaluations, scheduled at 4–6 months
intervals, spinal MRI showed complete regression of both
intra- end extraspinal tumors (Fig. 3) with normalization
of catecholamine metabolites urinary excretion. Patient
experienced further neurologic improvement making her
able to assume the upright posture.
Presently, at 2 years of age, patient is able to walk with
help of leg orthoses to correct feet abnormalities (equi-
novarus supinatus feet). In addition, she complains
chronic constipation requiring daily medication, and
neurogenic bladder necessitating multiple daily catheter-
izations and antibiotic prophylaxis.
Discussion
Children diagnosed with neuroblastoma presenting with
symptoms of EC have an excellent outcome in reason of
the favourable location of the primary tumour and the
rare metastatic spread [1–3]. Children at this age usually
have favorable biologic features (in particular, a single
copy of MYCN oncogene, and no abnormal 1p and 11q
chromosomes) [17, 20], and are thus excellent candi-
dates to cure. Although adequate studies could not be
performed due to the insufficient amount of tumour
Fig. 2 Histological pattern. Nests of undifferentiated round blue
cells, forming vague Homer-Wright rosettes. EE 200×
Fig. 3 MRI after conclusion of chemotherapy. Three planar T2WI (a, c, d) and coronal T1WI (b). The exam shows complete regression of the
tumor at both intra- and extraspinal compartments. Mild pyelectasia was detected in the right kidney
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tissue available, it is conceivable that the tumour of the
patient had normal biologic profile. On the other hand,
the majority of these patients develop long-term seque-
lae and this finding did not decrease since the first re-
ported series, back more than two decades ago [2]. The
risk of developing sequelae was greater in younger chil-
dren [4, 5]. The occurrence of symptoms of EC in new-
borns with neuroblastoma has been occasionally described
[6, 8–16]. Of note, all the reported cases have developed
mostly severe sequelae, with exception of two patients, both
described in 2008, surviving without significant late effects
[15, 16]. Both were delivered prematurely following late
pregnancy ultrasound detecting an extraspinal tumor mass.
Also in our patient anticipating delivery was decided
on the basis of late pregnancy ultrasound, that did dis-
cover the presence of oligohydramnios, but missed an
abdominal tumor mass. Two main reasons may account
for the failure: i) an abdominal mass may be too small at
the 36th week of pregnancy to be detected by ultra-
sound, and ii) at this time of pregnancy the amniotic
fluid is reduced and the mineralization of the fetal skel-
eton is increased, making it difficult to assess the para-
vertebral regions, especially when the fetus’ back is lying
opposite to the ultrasound beam.
Despite early delivery, prompt diagnostic work-up and
initiation of chemotherapy, the neurologic deficits only
partly regressed leading to the establishment of definitive
neurologic and functional sequelae. Therefore, the clin-
ical course of our patient did not replicate what oc-
curred to the two patients described in 2008, both
surviving free of sequelae. The fact that no further case
with similar favorable course has been reported since
and the unfavorable course of our patient, suggest that
anticipating delivery might be not always sufficient to
prohibit the development of late sequelae. Despite that,
it is conceivable that greater awareness of sonologists
might increase the possibility to recognize a paraverteb-
ral mass in a fetus. When this occurs, MRI should be
promptly performed to document the possible invasion
of the spinal canal. With these information in hands, the
interdisciplinary team may share with the family the de-
cision to anticipate delivery. In the case symptoms of EC
are evident at birth, prompt initiation of chemotherapy
may translate into lesser risk of long-term sequelae and
better quality of life for some of these patients.
Conclusions
We describe a newborn prematurely delivered because
of oligohydramnios, who had symptoms of EC at birth
secondary to a paraspinal neuroblastoma. Despite
prompt initiation of therapy, the neurologic deficits only
partly regressed leading to the establishment of severe
definitive physical disabilities. The unfavorable func-
tional outcome of our patient contrasts with the
successful course of two previous cases delivered prema-
turely. This difference in outcome suggests that antici-
pating delivery may not exempt from development of
sequelae. However, accurate ultrasonography in late
pregnancy is to be supported, as it may increase the
chance to detect an abdominal tumor and this may lead
to timely therapy and better functional outcome in some
of these patients.
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